IMV Inc. to Present at Upcoming Investor Conferences

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Chief Executive Officer Frederic Ors and Chief Financial Officer Pierre Labbé will present a corporate update at two upcoming investor conferences.

BIO Investor Forum, San Francisco, CA

• Date: Thursday, October 18, 2018
• Time: 9:00 a.m. PT
• Location: The Elizabeth Room, Westin St. Francis
• A live webcast of the presentation will be accessible via the following URL: http://www.veracast.com/webcasts/bio/investorforum2018/15132412139.cfm.   

Dawson James Small Cap Growth Conference, Jupiter, FL

• Date: Tuesday, October 30, 2018
• Time: 10:30 a.m. ET
• Location: Track 2 - Preserve Ballroom B, Wyndham Grand Jupiter Hotel
• A live webcast of the presentation will be accessible via the following URL: http://wsw.com/webcast/dawson4/imv/.

Both webcasts will be archived for 90 days following the live presentation. A copy of the presentations will also be available on the Events, Webcasts & Presentations page of IMV’s website: www.imv-inc.com.

About IMV

IMV Inc., formerly Immunovaccine Inc., is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of immunotherapies based on the Company’s proprietary drug delivery platform. This patented technology leverages a novel mechanism of action that enables the programming of immune cells in vivo, which are aimed at generating powerful new synthetic therapeutic capabilities. IMV’s lead candidate, DPX-Survivac, is a T cell-activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is currently assessing DPX-Survivac as a combination therapy in multiple clinical studies with Incyte and Merck. Connect at www.imv-inc.com.

Contacts for IMV:MEDIA Mike Beyer, Sam Brown Inc.T: [phone] E: [e-mail]

INVESTOR RELATIONSPierre Labbé, Chief Financial OfficerT: [phone] E: [e-mail]   

Patti Bank, Managing Director, Westwicke PartnersO: [phone]T: [phone] E: [e-mail]